-
Machine-learned biomarker identifies those at high risk for liver cancer
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a score... Read more -
KRAS mutation type may guide more effective cancer treatments
KRAS is the most frequently mutated oncogene across all human cancers. Although different KRAS mutations have long been thought to... Read more -
Cancer stress protein helps tumors hide from immune system
A protein made by stressed cancer cells helps lung and pancreatic tumors evade the immune system, a new study shows.... Read more -
Largest study of rare skin cancer in Mexican patients shows that it is more complex than previously thought
Genetic ancestry may play a key role in how acral melanoma, a rare and aggressive type of skin cancer, develops... Read more -
Recurrent prostate cancer: Two treatment strategies with uncertain outcomes compared
Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy.... Read more -
FDA approves noninvasive Optune Pax device for advanced pancreatic cancer
The U.S. Food and Drug Administration has approved a first-of-its-kind, noninvasive device, the Optune Pax, for the treatment of adult... Read more -
Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer
A new UCLA investigator-initiated study has found that adding immunotherapy to standard chemotherapy before surgery is safe and shows promise... Read more -
Novel biomarker predicts chemotherapy response in triple-negative breast cancer
Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to better account... Read more -
AI-powered liquid biopsy can classify pediatric brain tumors with 92% accuracy
Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to... Read more -
FDA-approved drug may reverse T-cell exclusion in fibrolamellar liver cancer
Immunotherapy—which activates the body's own immune system to kill cancer cells—has not worked well against a rare and fatal liver... Read more -
Why are more under-50s getting colorectal cancer? 'We don't know'
The death of US actor James Van Der Beek was just the latest reminder that colorectal cancer has been surging... Read more -
Researchers identify key mechanism driving progression of fatty liver disease to cancer
According to recent reports from the Korean government, the incidence of alcoholic liver disease—previously the leading indication for liver transplantation—has... Read more -
Why chemo causes unwanted side effects and how to treat them
Chemotherapy is one of the most common weapons in the cancer-treatment arsenal, but its side effects are well known. Hair... Read more -
Earlier immunotherapy is spreading in cancer care: Who benefits and what are the risks?
Immunotherapy given before or after surgery is increasingly used across several cancer areas. In an article published in the Journal... Read more -
Optimizing CAR T-cell therapy to tackle solid tumors
In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite prostaglandin E2 can... Read more
